Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis

Lignende værker

• The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
  af: Orchard, Trevor J., et al.
  Udgivet: (2017)
• Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial
  af: Davies, M. J., et al.
  Udgivet: (2016)
• Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials
  af: Rosenstock, Julio, et al.
  Udgivet: (2016)
• Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
  af: Xing, Zhenhua, et al.
  Udgivet: (2020)
• Randomized, double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
  af: Bergenstal, R. M., et al.
  Udgivet: (2016)